Amitriptyline-Mediated Cognitive Enhancement in Aged 3×Tg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity

Approximately 35 million people worldwide suffer from Alzheimer's disease (AD). Existing therapeutics, while moderately effective, are currently unable to stem the widespread rise in AD prevalence. AD is associated with an increase in amyloid beta (Aβ) oligomers and hyperphosphorylated tau, along with cognitive impairment and neurodegeneration. Several antidepressants have shown promise in improving cognition and alleviating oxidative stress in AD but have failed as long-term therapeutics. In this study, amitriptyline, an FDA-approved tricyclic antidepressant, was administered orally to aged and cognitively impaired transgenic AD mice (3×TgAD). After amitriptyline treatment, cognitive behavior testing demonstrated that there was a significant improvement in both long- and short-term memory retention. Amitriptyline treatment also caused a significant potentiation of non-toxic Aβ monomer with a concomitant decrease in cytotoxic dimer Aβ load, compared to vehicle-treated 3×TgAD controls. In addition, amitriptyline administration caused a significant increase in dentate gyrus neurogenesis as well as increases in expression of neurosynaptic marker proteins. Amitriptyline treatment resulted in increases in hippocampal brain-derived neurotrophic factor protein as well as increased tyrosine phosphorylation of its cognate receptor (TrkB). These results indicate that amitriptyline has significant beneficial actions in aged and damaged AD brains and that it shows promise as a tolerable novel therapeutic for the treatment of AD.

[1]  S. Temple,et al.  Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure. , 2010, Genes & development.

[2]  F. Nicoletti,et al.  β-Amyloid Monomers Are Neuroprotective , 2009, The Journal of Neuroscience.

[3]  Xin Wang,et al.  Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain , 2008, Brain Research Bulletin.

[4]  T. Ortiz,et al.  Complexity Analysis of Spontaneous Brain Activity in Alzheimer Disease and Mild Cognitive Impairment: An MEG Study , 2010, Alzheimer Disease and Associated Disorders.

[5]  L. Lue,et al.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.

[6]  R. Houtkooper,et al.  MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria , 2010, Nature Cell Biology.

[7]  Frank M LaFerla,et al.  Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease , 2006, The Journal of Neuroscience.

[8]  M. Tansey,et al.  Regulator of G-Protein Signaling 10 Promotes Dopaminergic Neuron Survival via Regulation of the Microglial Inflammatory Response , 2008, The Journal of Neuroscience.

[9]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[10]  D. Housman,et al.  Functional genomics reveals a family of eukaryotic oxidation protection genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Miyata,et al.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.

[12]  F. Baas,et al.  Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake. , 2008, Biochimica et biophysica acta.

[13]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[14]  Liping Huang,et al.  Zinc transporter 7 is located in the cis-Golgi apparatus of mouse choroid epithelial cells , 2006, Neuroreport.

[15]  R. Faull,et al.  Characterization of the Netrin/RGMa receptor neogenin in neurogenic regions of the mouse and human adult forebrain , 2010, The Journal of comparative neurology.

[16]  Xinnan Wang,et al.  Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules , 2007, Nature Neuroscience.

[17]  M. Mattson,et al.  Gonadal Transcriptome Alterations in Response to Dietary Energy Intake: Sensing the Reproductive Environment , 2009, PloS one.

[18]  J. Settleman,et al.  Distinct but Overlapping Functions for the Closely Related p190 RhoGAPs in Neural Development , 2006, Developmental Neuroscience.

[19]  R. Veerhuis,et al.  Neuroinflammation in Alzheimer's disease and prion disease , 2002, Glia.

[20]  M. Skalicky,et al.  Hippocampal signaling cascades are modulated in voluntary and treadmill exercise rats , 2007, Electrophoresis.

[21]  J. Kelly,et al.  Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Stuart Maudsley,et al.  Complex and Multidimensional Lipid Raft Alterations in a Murine Model of Alzheimer's Disease , 2010, International journal of Alzheimer's disease.

[23]  Jong Keun Kim,et al.  Expression of Brain-Specific Angiogenesis Inhibitor 2 (BAI2) in Normal and Ischemic Brain: Involvement of BAI2 in the Ischemia-Induced Brain Angiogenesis , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  V. Bodrikov,et al.  Reggies/Flotillins Regulate Retinal Axon Regeneration in the Zebrafish Optic Nerve and Differentiation of Hippocampal and N2a Neurons , 2009, The Journal of Neuroscience.

[25]  F. Baas,et al.  Abeta 1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner. , 2007, Antioxidants & redox signaling.

[26]  Stuart Maudsley,et al.  Minimal Peroxide Exposure of Neuronal Cells Induces Multifaceted Adaptive Responses , 2010, PloS one.

[27]  M. Krause,et al.  c-Abl, Lamellipodin, and Ena/VASP Proteins Cooperate in Dorsal Ruffling of Fibroblasts and Axonal Morphogenesis , 2010, Current Biology.

[28]  Jhi-Joung Wang,et al.  Amitriptyline Suppresses Neuroinflammation-dependent Interleukin-10-p38 Mitogen-activated Protein Kinase-Heme Oxygenase-1 Signaling Pathway in Chronic Morphine-infused Rats , 2009, Anesthesiology.

[29]  Keiko Takahashi,et al.  Ndrg4 enhances NGF‐induced ERK activation uncoupled with Elk‐1 activation , 2006, Journal of cellular biochemistry.

[30]  K. Becker,et al.  Growth Factor Signals in Neural Cells , 2009, Journal of Biological Chemistry.

[31]  M. Mattson,et al.  Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice , 2007, Experimental Neurology.

[32]  K. Ye,et al.  Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. , 2009, Chemistry & biology.

[33]  B. Spiegelman,et al.  Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. , 2006, Endocrine reviews.

[34]  C. Matrone,et al.  Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease , 2010, Developmental neurobiology.

[35]  I. Heuser,et al.  Serum Concentrations of Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Depressed Patients before and after Antidepressant Treatment , 2008, Pharmacopsychiatry.

[36]  Stuart Maudsley,et al.  iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease , 2008, PloS one.

[37]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[38]  Haiyun Xu,et al.  Dose-Related Effects of Chronic Antidepressants on Neuroprotective Proteins BDNF, Bcl-2 and Cu/Zn-SOD in Rat Hippocampus , 2003, Neuropsychopharmacology.

[39]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[40]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[42]  Israel Hernandez,et al.  The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule , 2009, The Journal of Neuroscience.

[43]  D. Selkoe,et al.  Aβ oligomers inhibit synapse remodelling necessary for memory consolidation , 2011, Neurobiology of Aging.

[44]  Norbert Nagy,et al.  Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. , 2008, Journal of molecular and cellular cardiology.

[45]  M. Trabucchi,et al.  Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors , 2009, International Psychogeriatrics.

[46]  T. Koyama,et al.  The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. , 2008, The Journal of clinical investigation.

[47]  Nick C Fox,et al.  Symptoms of Memory Loss as Predictors of Cognitive Impairment?: The Use and Reliability of Memory Ratings in a Clinic Population , 2007, Alzheimer disease and associated disorders.

[48]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[49]  Stuart Maudsley,et al.  Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents. , 2009, Current medicinal chemistry.

[50]  L. Ferrucci,et al.  Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging , 2010, PloS one.